What is Vir Biotechnology, Inc.'s EV / sales?

Vir Biotechnology, Inc. (VIR) reported EV / sales of 19× in Q1 2026.

How has Vir Biotechnology, Inc.'s EV / sales changed year-over-year?

Vir Biotechnology, Inc.'s EV / sales decreased by 35.7% year-over-year, from 29.6× to 19×.

What is the long-term trend for Vir Biotechnology, Inc.'s EV / sales?

Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s EV / sales has grown at a -24.4% compound annual growth rate (CAGR), from 41.1× to 10.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Vir Biotechnology, Inc. VIR EV / sales

EV / sales at other companies

AmgenAMGN

6.6×+0.1×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Gilead SciencesGILD

6.3×+0.9×

Viridian Therapeutics, Inc.VRDN

26.2×-3,303×

Iovance Biotherapeutics, Inc.IOVA

4.5×0.0×

Nuvation BioNUVB

9.9×-41.1×

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.71B+61.1%

Enterprise value$1.53B+102%

P/S26.2×-24.8×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

enterprise value/total revenue=19×

Based on the most recent quarter.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s EV / sales?: Vir Biotechnology, Inc. (VIR) reported EV / sales of 19× in Q1 2026.
How has Vir Biotechnology, Inc.'s EV / sales changed year-over-year?: Vir Biotechnology, Inc.'s EV / sales decreased by 35.7% year-over-year, from 29.6× to 19×.
What is the long-term trend for Vir Biotechnology, Inc.'s EV / sales?: Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s EV / sales has grown at a -24.4% compound annual growth rate (CAGR), from 41.1× to 10.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.